News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

HPV Infection and Its Link to Cancer

April 29, 2012
Article

Anna R. Giuliano, PhD, director of the newly created Center for Infection Research in Cancer at Moffitt Cancer Center, is world renowned for her research on the human papillomavirus (HPV) and the variety of cancers linked to it that affect both men and women. She was recently appointed to lead this new center to expand Moffitts efforts to find other links between infections and cancer.

Our goals with the new center are to discover new infectious agents and their association with cancers and to translate those discoveries into clinical trials, new screening methods and cancer prevention, said Giuliano, an international leader in HPV research who was named Moffitts Researcher of the Year for 2011. We also want to deliver new standards of care based on infection status and find more effective treatment interventions.

Dr. Giuliano was voted as the Researcher of the Year by her peers at Moffitt in recognition of her incredible record of accomplishment, says Thomas Sellers, PhD, director of the Moffitt Research Institute. She has demonstrated herself as an outstanding leader of the Program in Cancer Epidemiology, but in this new position she can have much greater influence in bringing together multidisciplinary teams to advance the fight against cancers with an infection component. We are confident that this center will become pre-eminent in the world.

Giuliano is an internationally recognized speaker and consultant who has served on numerous committees and investigative task forces.

Since the links between sexually transmitted HPV infections and a variety of cancers were firmly established in 1995, research into the HPV cancer link has expanded greatly. Estimates are that HPV infection causes 5 percent of all new cancers, such as cervical cancer (noted by the World Health Organization to be the second biggest cause of female cancer mortality worldwide), vaginal, vulvar, anal, and a subset of cancers of the head and neck.

There are more than100 types of HPV, explained Giuliano. Forty of these pose varying risks for the development of cancer. HPV-16 and HPV-18 together account for about 70 percent of cervical cancers globally. Recently, its been found that oral HPV-16 infection is strongly linked to the development of throat cancer.

Giuliano, who has been at Moffitt since 2004, has also led increased research into vaccines aimed at preventing HPV infection and related cancers for both men and women.

In 2004, the National Institutes of Health awarded her $10 million to determine the natural history of HPV in men and transmission of the HPV viruses that causes cervical cancer in women. The grant was renewed in 2009, allowing Dr. Giuliano and colleagues to study the progression of these infections in men to disease. This ongoing, multinational study, The HPV Infection in Men (HIM), is funded through the Program Announcement for Cancer Cohort Studies that followed 4,000 men in the United States, Brazil and Mexico.

Men have as much HPV infection as women, but it hasnt been clear how HPV infections progress in men, explains Giuliano.

Recently, Giuliano and colleagues completed a phase III international clinical trial demonstrating that the 4 valent HPV vaccine significantly reduces both infection and disease in men.

Infections contribute to at least 18 percent of all cancers worldwide, Sellers says. With the demonstration of the efficacy of vaccines to prevent viral infections and the evidence that infection-associated cancers may need to be treated differently, we see this as something that is central to Moffitts focus on personalized medicine.

 

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content

ACIP decides on vaccinations   (Adobe Stock 606491608 by N Lawrenson/peopleimages.com)

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

Richard Payerchin
June 27th 2025
Article

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.


US Department of Health and Human Services

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

Richard Payerchin
June 26th 2025
Article

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.


Jill Holdsworth, CIC, FAPIC, NREMT, CRCST, CHL; and Katie Belski, BSHCA, CRCST, CHL, CIS, CER, At HSPA25

Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski

Betsy Donahue, MA
June 26th 2025
Article

In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.


Infection Control Today's Hot Topics in IPC

Hot Topics for IPC for June 25, 2025: The Future of ACIP, Measles, and More

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
June 25th 2025
Article

This Hot Topics for IPC covers the latest on ACIP, vaccines, and a study on contact precautions for MRSA.


Infection prevention personnel in a training class.   (Adobe Stock 1196827000 by Carlo)

A Profession Without a Path: Reforming Infection Prevention and Control Education and Workforce Development

Shahbaz Salehi, MD, MPH, MSHIA;Anna Arifin, MD, MBA, MT, CIC
June 20th 2025
Article

Despite its critical role in patient safety, infection prevention and control (IPC) remains one of health care’s most misunderstood and understructured professions. While COVID-19 thrust IPC into the spotlight, the field still lacks a clear entry path, standardized training, and broad institutional recognition, leaving many professionals to learn on the job with minimal guidance.


Dr Erin Allmann Updyke and Erin Welsh, co-hosts of “This Podcast Will Kill You.”  (Image credit: author)

Combating Contagion, Confusion, and Public Mistrust: The Infection Preventionist’s Role in the Infodemic Era

Carole W. Kamangu, MPH, RN, CIC
June 19th 2025
Article

Infection preventionists are at the forefront of the infodemic; the keynote session offered suggestions on how they can combat and mitigate misinformation.

Related Content

ACIP decides on vaccinations   (Adobe Stock 606491608 by N Lawrenson/peopleimages.com)

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

Richard Payerchin
June 27th 2025
Article

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.


US Department of Health and Human Services

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

Richard Payerchin
June 26th 2025
Article

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.


Jill Holdsworth, CIC, FAPIC, NREMT, CRCST, CHL; and Katie Belski, BSHCA, CRCST, CHL, CIS, CER, At HSPA25

Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski

Betsy Donahue, MA
June 26th 2025
Article

In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.


Infection Control Today's Hot Topics in IPC

Hot Topics for IPC for June 25, 2025: The Future of ACIP, Measles, and More

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
June 25th 2025
Article

This Hot Topics for IPC covers the latest on ACIP, vaccines, and a study on contact precautions for MRSA.


Infection prevention personnel in a training class.   (Adobe Stock 1196827000 by Carlo)

A Profession Without a Path: Reforming Infection Prevention and Control Education and Workforce Development

Shahbaz Salehi, MD, MPH, MSHIA;Anna Arifin, MD, MBA, MT, CIC
June 20th 2025
Article

Despite its critical role in patient safety, infection prevention and control (IPC) remains one of health care’s most misunderstood and understructured professions. While COVID-19 thrust IPC into the spotlight, the field still lacks a clear entry path, standardized training, and broad institutional recognition, leaving many professionals to learn on the job with minimal guidance.


Dr Erin Allmann Updyke and Erin Welsh, co-hosts of “This Podcast Will Kill You.”  (Image credit: author)

Combating Contagion, Confusion, and Public Mistrust: The Infection Preventionist’s Role in the Infodemic Era

Carole W. Kamangu, MPH, RN, CIC
June 19th 2025
Article

Infection preventionists are at the forefront of the infodemic; the keynote session offered suggestions on how they can combat and mitigate misinformation.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News